// App-Quantinova.ai

TCT-181 : 5-Year Outcomes of Patients Undergoing Everolimus-Eluting Bioresorbable Scaffold Implantation During Daily Clinical Routine: Final Results From the ISAR-Absorb Registry

Researchers

Presenter

  • Jens Wiebe

Principal Investigators

  • Petra Hoppmann

  • Tobias Rheude

  • Himanshu Rai

  • Roisin Colleran

  • Felix Voll

  • Salvatore Cassese

  • Michael Joner

  • Karl-Ludwig Laugwitz

  • Adnan Kastrati

  • Robert Byrne

Medical Centers

  • Medizinische Klinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany

  • Deutsches Herzzentrum München, München, Germany

  • Deutsches Herzzentrum Munchen, Technische Universitat Munchen, Munich, Germany

  • ISAResearch Centre, Deutsches Herzzentrum München (German Heart Centre Munich), Munich, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved